Dan Troy

Daniel E.
Troy is currently the Chairman at the National Chamber Litigation Center since 2008, the Secretary & Director at Human Genome Sciences, Inc. since 2012, the Director at NeuroRx, Inc. since 2018, and a Member of The American Law Institute.
Previously, he served as the Chairman-Administrative Law Section at the American Bar Association in 2007, Chairman of the Civil Justice Reform Group, Independent Director at NRX Pharmaceuticals, Inc. from 2021 to 2022, Chief Business & Administrative Officer at Valo Health, Inc., Senior Vice President & General Counsel at GSK Plc from 2008 to 2018, Chief Counsel at the US Food & Drug Administration, and Partner at Sidley Austin LLP from 2005 to 2008.
He also has a background in law, having studied at Columbia Law School and being a member of the Law Review and a Kent Scholar.
He completed his undergraduate studies at Cornell University.